Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Condition:   Stage III Non-small-cell Lung Cancer Interventions:   Other: Neoadjuvant therapy;   Other: Chemotherapy concurrent with radiotherapy;   Radiation: Radiotherapy;   Drug: Nivolumab;   Other: Observation Sponsor:   Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials